The Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021 passed the House of Representatives last night and is likely to pass through the Senate without amendments.
Cannabiz co-founder Martin Lane and editor-at-large Rhys Cohen spoke with Australian Medicinal Cannabis Association (AMCA) secretary and lawyer Teresa Nicoletti and head of legal and regulatory affairs at Cann Group Steven Notaro about:
- the background to the bill
- what it sets out to achieve
- the implications for the cannabis industry
- what it means for approval times and patient access